| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722764 | HPB | 2018 | 8 Pages |
Abstract
In a modern, multi-institutional cohort of patients undergoing curative-intent resection for HC, VR appears to be a safe procedure in a highly selected subset, although long-term survival outcomes appear equivalent. VR should be considered only in select patients based on tumor and patient characteristics.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Gregory V. Schimizzi, Linda X. Jin, Jesse T. IV, Bradley A. Krasnick, Cecilia G. Ethun, Timothy M. Pawlik, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Sharon M. Weber, Ahmed Salem, William G. Hawkins, Steven M. Strasberg,